SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KENYON LAWRENCE A

(Last)

(First)

(Middle)

300 TICE BLVD

(Street)

WOODCLIFF LAKE

07677

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PAR PHARMACEUTICAL COMPANIES, INC. [ PRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2010

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2010		M		21,439	A	$13.06	42,088	D
Common Stock	03/03/2010		S		3,261	D	$25.185	38,827	D
Common Stock	03/03/2010		S		700	D	$25.187	38,127	D
Common Stock	03/03/2010		S		4,711	D	$25.19	33,416	D
Common Stock	03/03/2010		S		500	D	$25.195	32,916	D
Common Stock	03/03/2010		S		2,800	D	$25.2	30,116	D
Common Stock	03/03/2010		S		2,700	D	$25.205	27,416	D
Common Stock	03/03/2010		S		100	D	$25.207	27,316	D
Common Stock	03/03/2010		S		100	D	$25.2075	27,216	D
Common Stock	03/03/2010		S		1,041	D	$25.21	26,175	D
Common Stock	03/03/2010		S		200	D	$25.215	25,975	D
Common Stock	03/03/2010		S		200	D	$25.217	25,775	D
Common Stock	03/03/2010		S		3,426	D	$25.22	22,349	D
Common Stock	03/03/2010		S		100	D	$25.24	22,249	D
Common Stock	03/03/2010		S		100	D	$25.25	22,149	D
Common Stock	03/03/2010		S		600	D	$25.255	21,549	D
Common Stock	03/03/2010		S		400	D	$25.26	21,149	D
Common Stock	03/03/2010		S		300	D	$25.265	20,849	D
Common Stock	03/03/2010		S		200	D	$25.27	20,649⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, Option to Buy	$13.06	03/03/2010		M			21,439	⁽²⁾	01/07/2019	Common Stock	21,439	$0	64,319	D

Explanation of Responses:

1. Represents all shares of Restricted Stock held by Mr. Kenyon

2. Mr. Kenyon was granted an option to purchase 85,758 shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% (21,439 shares) vested on 1/8/2010 (the first anniversary of the date of grant); an additional 25% vest on each anniversary thereafter until vested.

	/s/ Marian E. Gustafson for Lawrence A. Kenyon	03/03/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.